Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L L Thomas

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Medical Toxicology and Adverse Drug Experience|July 1, 1988
Clinical management of cytotoxic drug overdoseL L Thomas, M J Mertens, A E von dem Borne, et al.
Journal of Leukocyte Biology|December 1, 1992
Eosinophil granule proteins in peripheral blood granulocytesR I Abu-Ghazaleh, S L Dunnette, D A Loegering, et al.
Journal of Immunological Methods|September 15, 1999
Discordant and anomalous results among cytotoxicity assays: the confounding properties of eosinophil granule major basic protein on cell viability assaysH Kubo, D A Loegering, Y Tohda, et al.
Cell Death and Differentiation|March 5, 2016
PACS-2 mediates the ATM and NF-κB-dependent induction of anti-apoptotic Bcl-xL in response to DNA damageJ Barroso-González, S Auclair, S Luan, et al.
British Journal of Haematology|July 1, 1995
Low-intensity oral anticoagulation in sickle-cell disease reverses the prethrombotic state: promises for treatment?H J Wolters, H ten Cate, L L Thomas, et al.
Infection|March 1, 1997
Pneumocystis carinii pneumonia in HIV-negative patients with haematologic diseaseJ van der Lelie, D Venema, E J Kuijper, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1995
Expression, purification, and characterization of the recombinant proform of eosinophil granule major basic proteinP Popken-Harris, M McGrogan, D A Loegering, et al.
The Journal of Biological Chemistry|May 13, 1999
A novel and highly divergent homolog of human eosinophil granule major basic proteinD A Plager, D A Loegering, D A Weiler, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Medical Toxicology and Adverse Drug Experience|July 1, 1988
Clinical management of cytotoxic drug overdoseL L Thomas, M J Mertens, A E von dem Borne, et al.
Journal of Leukocyte Biology|December 1, 1992
Eosinophil granule proteins in peripheral blood granulocytesR I Abu-Ghazaleh, S L Dunnette, D A Loegering, et al.
Journal of Immunological Methods|September 15, 1999
Discordant and anomalous results among cytotoxicity assays: the confounding properties of eosinophil granule major basic protein on cell viability assaysH Kubo, D A Loegering, Y Tohda, et al.
Cell Death and Differentiation|March 5, 2016
PACS-2 mediates the ATM and NF-κB-dependent induction of anti-apoptotic Bcl-xL in response to DNA damageJ Barroso-González, S Auclair, S Luan, et al.
British Journal of Haematology|July 1, 1995
Low-intensity oral anticoagulation in sickle-cell disease reverses the prethrombotic state: promises for treatment?H J Wolters, H ten Cate, L L Thomas, et al.
Infection|March 1, 1997
Pneumocystis carinii pneumonia in HIV-negative patients with haematologic diseaseJ van der Lelie, D Venema, E J Kuijper, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1995
Expression, purification, and characterization of the recombinant proform of eosinophil granule major basic proteinP Popken-Harris, M McGrogan, D A Loegering, et al.
The Journal of Biological Chemistry|May 13, 1999
A novel and highly divergent homolog of human eosinophil granule major basic proteinD A Plager, D A Loegering, D A Weiler, et al.
Pageof 8